B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07239323	In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies	recruiting	Phase 1	24	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Nov 20, 2025	clinicaltrials
NCT03233854	CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies	active not recruiting	Phase 1	56	Stanford UniversityOTHER	1	Nov 18, 2025	clinicaltrials